Jazz Pharmaceuticals Announces Pricing Of Private Offering Of Senior Notes

(RTTNews) - Jazz Pharmaceuticals plc (JAZZ) announced the pricing of $850 million aggregate principal amount of 3.125% exchangeable senior notes due 2030 in a private offering by Jazz Investments I Limited, its wholly-owned subsidiary, to qualified institutional buyers. The issue https://www.nasdaq.com/articles/jazz-pharmaceuticals-announces-pricing-private-offering-senior-notes